Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin

Biochemical and Biophysical Research Communications

Volumn 342, Issue 4, 2006, Pages 1174-1177

  Xu, Ning ^a   Nilsson Ehle, Peter ^a   Ahrén, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Alloxan; Apolipoprotein M; Diabetic mellitus; Insulin; Kidney; Liver; Mouse

Indexed keywords

ALLOXAN; APOLIPOPROTEIN M; GLUCOSE; INSULIN; LEPTIN; MESSENGER RNA;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVERSAL REACTION;

ADAPTATION, PHYSIOLOGICAL; ALLOXAN; ANIMALS; APOLIPOPROTEINS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; INSULIN; KIDNEY; LIVER; MICE;

ANIMALIA;

EID: 33644915791     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.022     Document Type: Article

References (17)

1. N. Xu, and B. Dahlback A novel human apolipoprotein (apoM) J. Biol. Chem. 274 1999 31286 31290
2. X.Y. Zhang, X. Dong, L. Zheng, G.H. Luo, Y.H. Liu, U. Ekstrom, P. Nilsson-Ehle, Q. Ye, and N. Xu Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization Acta Histochem. 105 2003 67 72
3. X.Y. Zhang, G.Q. Jiao, M. Hurtig, X. Dong, L. Zheng, G.H. Luo, P. Nilsson-Ehle, Q. Ye, and N. Xu Expression pattern of apolipoprotein M during mouse and human embryogenesis Acta Histochem. 106 2004 123 128
4. C. Wolfrum, M.N. Poy, and M. Stoffel Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis Nat. Med. 11 2005 418 422
5. N. Xu, P. Nilsson-Ehle, M. Hurtig, and B. Ahren Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo Biochem. Biophys. Res. Commun. 321 2004 916 921
6. N. Xu, P. Nilsson-Ehle, and B. Ahren Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects J. Nutr. Biochem. 15 2004 579 582
7. N. Xu, X.Y. Zhang, X. Dong, U. Ekstrom, Q. Ye, and P. Nilsson-Ehle Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells Biochem. Biophys. Res. Commun. 292 2002 944 950
8. N. Xu, M. Hurtig, X.Y. Zhang, Q. Ye, and P. Nilsson-Ehle Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells Biochim. Biophys. Acta 1683 2004 33 37
9. R.H. Bell Jr., and R.J. Hye Animal models of diabetes mellitus: physiology and pathology J. Surg. Res. 35 1983 433 460
10. B. Ahren, and G. Sundkvist Long-term effects of alloxan in mice Int. J. Pancreatol. 17 1995 197 201
11. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
12. G. Luo, X. Zhang, P. Nilsson-Ehle, and N. Xu Apolipoprotein M Lipids Health Dis. 3 2004 21
13. G. Luo, M. Hurtig, X. Zhang, P. Nilsson-Ehle, and N. Xu Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells Biochim. Biophys. Acta 1734 2005 198 202
14. P.J. Havel, J.Y. Uriu-Hare, T. Liu, K.L. Stanhope, J.S. Stern, C.L. Keen, and B. Ahren Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin Am. J. Physiol. 274 1998 R1482 R1491
15. J. Duan, B. Dahlback, and B.O. Villoutreix Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis FEBS Lett. 499 2001 127 132
16. D.R. Flower, A.C. North, and C.E. Sansom The lipocalin protein family: structural and sequence overview Biochim. Biophys. Acta 1482 2000 9 24
17. E. Rassart, A. Bedirian, S. Do Carmo, O. Guinard, J. Sirois, L. Terrisse, and R. Milne Apolipoprotein D Biochim. Biophys. Acta 1482 2000 185 198